search for


Development of Agenda for Pharmaceutical Care Service Research and Development using the Analytical Hierarchy Process
Korean J Clin Pharm 2019;29(1):45-55
Published online March 31, 2019
© 2019 Korean College of Clinical Pharmacy.

Nayoung Han1, Chae-Reen Jeong1, Yun-Kyoung Song1,2, Jeong-Hyun Yoon3, Sunmee Jang4, Eui-Kyung Lee5, Hyun Taek Shin6, Young Sook Lee7, Hyun Soon Sohn6,8, Eunhee Ji4, Dong Chul Suh9, Daekyung Kim9, and Jung Mi Oh1*

1College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea
2College of Pharmacy, Catholic University of Daegu, Gyeongbuk 38430, Republic of Korea
3College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea
4College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea
5College of Pharmacy, Sungkyunkwan University, Gyeonggi-do 16419, Republic of Korea
6College of Pharmacy, Sookmyung Women’s University, Seoul 04310, Republic of Korea
7College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea
8College of Pharmacy, CHA University, Gyeonggi-do 11160, Republic of Korea
9College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea
Correspondence to: Jung Mi Oh, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea
Tel: +82-2-880-7997, Fax: +82-2-766-9560, E-mail:
Received March 9, 2019; Revised March 18, 2019; Accepted March 18, 2019.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Although the importance of pharmaceutical care service has been growing to meet the needs of customers with the improvement of clinical and humanistic outcomes, there was not a systematic strategy to promote research in Korea. The aim of this study was to suggest the core agendas for pharmaceutical care services research and development (R&D) considering priorities. Methods: Based on desk researches, we developed R&D agendas for the needs of improving pharmaceutical care services in the area of institution, community, and public health. To determine the priority of agendas in developing pharmaceutical care service, analytic hierarchy process (AHP) analysis was performed by the 14 experts. Criteria and subcriteria were assessed for significance by pairwise comparisons. Then, agendas were evaluated for importance according to each subcriteria, and rank ordered considering the weight calculated by multiplying the importance scores of the criteria and the subcriteria. Results: We derived 25 agendas including 13 for institutional pharmaceutical care service, 8 for community pharmaceutical care service, and 4 for public-health related pharmaceutical care service. AHP model was constructed based on 4 criteria and 8 subcriteria by a hierarchical structure. From the AHP survey, the ‘Development of pharmaceutical care service for metabolic and chronic disease’ agenda accounted for the highest priority. Conclusion: We have developed the R&D agendas of the pharmaceutical care service which should be promoted. The results should be utilized by the government to nationally support the development of the standards and relevant regulations related to pharmaceutical care services in Korea.
Keywords : Analytic hierarchy process, pharmaceutical care service, service R&D

March 2019, 29 (1)
Full Text(PDF) Free

Social Network Service

Cited By Articles
  • CrossRef (0)

Funding Information